Dr. Muslin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
490 Arsenal Way
Suite 210
East Watertown, MA 02472Phone+1 617-872-9174- Is this information wrong?
Summary
- I am currently the Chief Development Officer at Tectonic Therapeutic in Watertown, MA.
Education & Training
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 1987 - 1989
- Brigham and Women's HospitalResidency, Internal Medicine, 1984 - 1987
- Harvard Medical SchoolClass of 1984, M.D.
- Yale UniversityB.A., History, Magna Cum Laude, 1976 - 1980
Certifications & Licensure
- MO State Medical License 1994 - 2015
Publications & Presentations
PubMed
- 9 citationsEndothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled...Luc Bergougnan, Grit Andersen, Leona Plum-Mörschel, Maria Francesca Evaristi, Bruno Poirier, Agnes Tardat, Marcel Ermer, Theresa Herbrand, Jorge Arrubla, Hans Veit Coe...> ;British Journal of Clinical Pharmacology. 2021 May 1
- 9 citationsFirst-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sp...Luc Bergougnan, Sara Armani, Georg Golor, Agnes Tardat, Olivier Vitse, Fabrice Hurbin, Michel Scemama, Franck Poitiers, Radzik Davide, Gaudin Christophe, Lionel Hovsep...> ;British Journal of Clinical Pharmacology. 2021 Feb 1
- 26 citationsA G protein-biased S1P1 agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers.Bruno Poirier, Véronique Briand, Dieter Kadereit, Matthias Schäfer, Paulus Wohlfart, Marie-Claire Philippo, Dominique Caillaud, Laurent Gouraud, Patrick Grailhe, Jean-...> ;Science Signaling. 2020 Jun 2
- Join now to see all
Press Mentions
- Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-protein Coupled Receptor (GPCR)-Targeted TherapiesApril 15th, 2021
Grant Support
- Altered Cardiac Myocyte Signaling In Diabetic Myocardium And Functional SequelaeNational Heart, Lung, And Blood Institute2009
- Principles In Cardiovascular Research Training ProgramNational Heart, Lung, And Blood Institute2006–2009
- MAP Kinase And AKT Signaling In Congestive Heart FailureNational Heart, Lung, And Blood Institute2005–2009
- RGS Protein Function In Cardiac PhysiologyNational Heart, Lung, And Blood Institute2002–2008
- G Protein Coupling Of Lipid Metabolism In Diabetic HeartNational Heart, Lung, And Blood Institute2002–2005
- RGS Protein Function In Cardiac PhysiologyNational Heart, Lung, And Blood Institute2000–2002
- 14-3-3 Protein Function In Cell Growth And MotilityNational Institute Of General Medical Sciences1997–2001
- PDGF Receptor Function In Embryonic DevelopmentNational Heart, Lung, And Blood Institute1994–1996
- PDGF Receptor Function In Embryonic DevelopmentNational Heart, Lung, And Blood Institute1992–1994
- The Role Of The PDGF Receptor In AtherogenesisNational Heart, Lung, And Blood Institute1989–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: